2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Czirr James C | 10% Owner | 5,832,207 | Dec 4, 2025 |
| 10x Fund, L.P. | 10% Owner | 5,832,207 | Dec 4, 2025 |
| 10x Capital Management, Llc | 10% Owner | 5,832,207 | Dec 4, 2025 |
| Martin Rod D | Director | 2,776,186 | Jul 8, 2015 |
| Carson Benjamin Sr | — | 100,000 | Feb 16, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | Feb 9, 2026 | ELDRED KARY | Director | Buy | 60.0 | +300 | 0.43% | ✗ | $810 |
| Jan 16, 2026 | Jan 22, 2026 | LEWIS JOEL | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | CARSON BENJAMIN SR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | Zordani Richard A. Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | Jamil Khurram | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | FREEMAN KEVIN D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | ELDRED KARY | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | LEWIS JOEL | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | CALLICUTT JACK W | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | Shlevin Harold H. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | OMENN GILBERT S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | AMELIO GILBERT F | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | Schwartz Elissa J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2026 | Jan 21, 2026 | Uihlein Richard E | Director | Neutral | 55.0 | +13,158 | 0.13% | ✗ | - |
| Jan 5, 2026 | Jan 13, 2026 | LEWIS JOEL | CEO | Sell | 42.5 | -56,332 | -6.75% | ✗ | $218.6K |
| Jan 2, 2026 | Jan 6, 2026 | LEWIS JOEL | CEO | Sell | 28.8 | -84,000 | -9.14% | ✓ | $321.1K |
| Jan 2, 2026 | Jan 6, 2026 | CALLICUTT JACK W | CFO | Sell | 11.3 | -60,000 | -88.74% | ✓ | $233.4K |
| Jan 2, 2026 | Jan 6, 2026 | Jamil Khurram | Chief Medical Officer | Sell | 11.3 | -60,000 | -46.73% | ✓ | $232.4K |
| Dec 31, 2025 | Jan 5, 2026 | Jamil Khurram | Chief Medical Officer | Sell | 13.1 | -8,125 | -100.00% | ✓ | $33.1K |
| Dec 23, 2025 | Dec 23, 2025 | FREEMAN KEVIN D | Director | Buy | 83.8 | +5,500 | 3.72% | ✗ | $19.5K |
| Dec 23, 2025 | Dec 23, 2025 | FREEMAN KEVIN D | Director | Buy | 83.8 | +5,500 | 4.17% | ✗ | $19.5K |
| Dec 23, 2025 | Dec 23, 2025 | ELDRED KARY | Director | Buy | 77.5 | +700 | 1.01% | ✗ | $2.6K |
| Dec 23, 2025 | Dec 23, 2025 | FREEMAN KEVIN D | Director | Buy | 83.8 | +5,500 | 4.17% | ✗ | $19.5K |
| Dec 23, 2025 | Dec 23, 2025 | ELDRED KARY | Director | Buy | 77.5 | +700 | 1.01% | ✗ | $2.6K |
| Dec 17, 2025 | Dec 19, 2025 | LEWIS JOEL | CEO | Sell | 47.5 | -7,829 | -0.93% | ✓ | $55.2K |
| Dec 17, 2025 | Dec 19, 2025 | Jamil Khurram | Chief Medical Officer | Sell | 10.0 | -19,442 | -100.00% | ✓ | $136.9K |
| Dec 17, 2025 | Dec 19, 2025 | Shlevin Harold H. | Director | Sell | 10.0 | -24,499 | -79.03% | ✓ | $172.4K |
| Nov 24, 2025 | Dec 18, 2025 | 10X Fund, L.P. | 10% Owner | Sell | 32.5 | -54,681 | -0.96% | ✗ | $204.3K |
| Dec 12, 2025 | Dec 16, 2025 | Shlevin Harold H. | Director | Sell | 10.0 | -28,210 | -55.73% | ✓ | $177.2K |
| Dec 8, 2025 | Dec 10, 2025 | Shlevin Harold H. | Director | Sell | 5.0 | -175,790 | -66.23% | ✓ | $1.1M |
| Dec 2, 2025 | Dec 8, 2025 | 10X Fund, L.P. | 10% Owner | Sell | 20.0 | -162,069 | -2.78% | ✗ | $920.9K |
| Dec 2, 2025 | Dec 4, 2025 | 10X Fund, L.P. | 10% Owner | Sell | 20.0 | -150,000 | -2.57% | ✗ | $851.7K |
| Nov 17, 2025 | Nov 19, 2025 | LEWIS JOEL | CEO | Sell | 45.0 | -22,463 | -1.33% | ✓ | $136.4K |
| Nov 17, 2025 | Nov 19, 2025 | CALLICUTT JACK W | CFO | Sell | 7.5 | -77,920 | -67.18% | ✓ | $478.8K |
| Nov 13, 2025 | Nov 14, 2025 | Jamil Khurram | Chief Medical Officer | Sell | 7.5 | -121,117 | -87.11% | ✓ | $662.5K |
| Nov 11, 2025 | Nov 12, 2025 | 10X Fund, L.P. | 10% Owner | Sell | 32.5 | -40,000 | -0.68% | ✗ | $210K |
| Nov 10, 2025 | Nov 12, 2025 | LEWIS JOEL | CEO | Sell | 53.8 | -1,867 | -0.22% | ✓ | $11.3K |
| Nov 10, 2025 | Nov 12, 2025 | CALLICUTT JACK W | CFO | Sell | 23.8 | -5,291 | -18.81% | ✓ | $31.9K |
| Nov 5, 2025 | Nov 7, 2025 | LEWIS JOEL | CEO | Sell | 58.8 | -200 | -0.02% | ✓ | $1.2K |
| Nov 5, 2025 | Nov 7, 2025 | CALLICUTT JACK W | CFO | Sell | 46.3 | -600 | -2.56% | ✓ | $3.6K |
| Nov 3, 2025 | Nov 5, 2025 | LEWIS JOEL | CEO | Sell | 47.5 | -15,720 | -0.93% | ✓ | $95.3K |
| Nov 3, 2025 | Nov 5, 2025 | CALLICUTT JACK W | CFO | Sell | 10.0 | -32,439 | -41.52% | ✓ | $196.7K |
| Oct 22, 2025 | Oct 24, 2025 | 10X Fund, L.P. | 10% Owner | Sell | 32.5 | -50,000 | -0.84% | ✗ | $246.8K |
| Apr 22, 2024 | Oct 10, 2025 | 10X Fund, L.P. | 10% Owner | Sell | 40.0 | -25,000 | -0.42% | ✗ | $76.5K |
| Sep 12, 2025 | Sep 15, 2025 | CALLICUTT JACK W | CFO | Sell | 10.0 | -8,706 | -53.35% | ✓ | $56.1K |
| Sep 12, 2025 | Sep 15, 2025 | LEWIS JOEL | CEO | Sell | 45.0 | -14,000 | -1.65% | ✓ | $89K |
| Jul 21, 2025 | Jul 22, 2025 | ELDRED KARY | Director | Buy | 77.5 | +1,000 | 1.47% | ✗ | $2.9K |
| Jul 17, 2025 | Jul 18, 2025 | FREEMAN KEVIN D | Director | Buy | 83.8 | +5,000 | 3.50% | ✗ | $14.5K |
| Feb 3, 2025 | Jun 11, 2025 | CZIRR JAMES C | 10% Owner | Buy | 27.5 | -19,000 | -2.56% | ✗ | $6K |
| Mar 31, 2024 | Jun 11, 2025 | CZIRR JAMES C | 10% Owner | Buy | 43.8 | -21,200 | -0.35% | ✗ | $12K |
| Mar 3, 2025 | Mar 5, 2025 | LEWIS JOEL | CEO | Neutral | 47.5 | -56,420 | -6.33% | ✗ | - |
| Jan 23, 2025 | Jan 30, 2025 | Shlevin Harold H. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | Zordani Richard A. Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | Uihlein Richard E | Director | Neutral | 60.0 | +32,520 | 0.32% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | Schwartz Elissa J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | Rubin Marc | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | OMENN GILBERT S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | LEWIS JOEL | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | Jamil Khurram | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | FREEMAN KEVIN D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | ELDRED KARY | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | CARSON BENJAMIN SR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | CALLICUTT JACK W | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2025 | Jan 27, 2025 | OMENN GILBERT S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 30, 2024 | Dec 31, 2024 | Shlevin Harold H. | Director | Buy | 90.0 | +6,500 | 74.66% | ✗ | $7.5K |
| Dec 23, 2024 | Dec 26, 2024 | Jamil Khurram | Chief Medical Officer | Sell | 13.8 | -13,654 | -34.14% | ✓ | $12K |
| Dec 23, 2024 | Dec 26, 2024 | LEWIS JOEL | CEO | Sell | 36.3 | -56,000 | -5.86% | ✓ | $49.6K |
| Dec 23, 2024 | Dec 26, 2024 | CALLICUTT JACK W | CFO | Sell | 13.8 | -40,000 | -84.01% | ✓ | $35.5K |
| Dec 24, 2024 | Dec 26, 2024 | Zordani Richard A. Jr. | Director | Buy | 90.0 | +10,000 | 29.34% | ✗ | $8.2K |
| Dec 24, 2024 | Dec 26, 2024 | ELDRED KARY | Director | Buy | 91.3 | +13,469 | 24.65% | ✗ | $11K |
| Dec 24, 2024 | Dec 26, 2024 | FREEMAN KEVIN D | Director | Buy | 85.0 | +10,000 | 7.53% | ✗ | $8.1K |
| Oct 23, 2024 | Oct 23, 2024 | ELDRED KARY | Director | Buy | 67.5 | +500 | 0.92% | ✗ | $1.3K |
| Oct 17, 2024 | Oct 17, 2024 | FREEMAN KEVIN D | Director | Buy | 67.5 | +1,300 | 0.99% | ✗ | $3.4K |
| Oct 16, 2024 | Oct 16, 2024 | FREEMAN KEVIN D | Director | Buy | 86.3 | +10,000 | 8.23% | ✗ | $27K |
| Aug 23, 2024 | Aug 26, 2024 | Zordani Richard A. Jr. | Director | Buy | 90.0 | +3,500 | 11.44% | ✗ | $8.1K |
| Aug 1, 2024 | Aug 5, 2024 | Jamil Khurram | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 5, 2024 | Jamil Khurram | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 22, 2024 | Jul 23, 2024 | ELDRED KARY | Director | Buy | 67.5 | +400 | 0.74% | ✗ | $956 |
| Jan 16, 2024 | Jul 23, 2024 | ELDRED KARY | Director | Buy | 67.5 | +400 | 0.74% | ✗ | $956 |
| Jun 20, 2024 | Jun 20, 2024 | FREEMAN KEVIN D | Director | Buy | 77.5 | +2,500 | 2.10% | ✗ | $5.9K |
| Apr 30, 2024 | Apr 30, 2024 | Zordani Richard A. Jr. | Director | Buy | 82.5 | +1,000 | 3.38% | ✗ | $3.5K |
| Apr 24, 2024 | Apr 25, 2024 | LEWIS JOEL | CEO | Buy | 55.0 | +1,000 | 0.11% | ✗ | $3.4K |
| Mar 31, 2023 | Apr 25, 2024 | CZIRR JAMES C | 10% Owner | Buy | 61.3 | +2,000 | 0.26% | ✗ | $12K |
| Apr 22, 2024 | Apr 25, 2024 | CZIRR JAMES C | 10% Owner | Sell | 40.0 | -25,000 | -0.42% | ✗ | $76.5K |
| Apr 22, 2024 | Apr 22, 2024 | FREEMAN KEVIN D | Director | Buy | 77.5 | +2,500 | 2.15% | ✗ | $7.5K |
| Apr 9, 2024 | Apr 9, 2024 | FREEMAN KEVIN D | Director | Neutral | 77.5 | +2,063 | 1.80% | ✗ | - |
| Mar 1, 2024 | Mar 4, 2024 | LEWIS JOEL | CEO | Neutral | 47.5 | -152,584 | -14.53% | ✗ | - |
| Feb 16, 2024 | CARSON BENJAMIN SR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 24, 2024 | Feb 7, 2024 | Zordani Richard A. Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Feb 7, 2024 | Uihlein Richard E | Director | Neutral | 60.0 | +23,256 | 0.23% | ✗ | - |
| Jan 24, 2024 | Feb 7, 2024 | Schwartz Elissa J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Feb 7, 2024 | Rubin Marc | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Feb 7, 2024 | OMENN GILBERT S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Feb 7, 2024 | LEWIS JOEL | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Feb 7, 2024 | FREEMAN KEVIN D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Feb 7, 2024 | ELDRED KARY | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Feb 7, 2024 | CARSON BENJAMIN SR | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Feb 7, 2024 | CALLICUTT JACK W | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Feb 7, 2024 | Boudes Pol F | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 24, 2024 | Feb 7, 2024 | AMELIO GILBERT F | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |